ASX - By Stock
|
MX1 |
Re:
Investors Conference Call
|
|
willbah
|
35 |
10K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
LVT |
Re:
How Do SaaS Companies Perform in a Recession?
|
|
willbah
|
23 |
11K |
0 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
23
|
11K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Heads up: OPT is about to skyrocket
|
|
willbah
|
46 |
24K |
1 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
46
|
24K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
Buy Recommendation
|
|
willbah
|
82 |
111K |
6 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
82
|
111K
|
6
|
|
ASX - By Stock
|
COF |
Re:
another goner
|
|
willbah
|
15 |
5.9K |
0 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
15
|
5.9K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Micro-X (ASX:MX1) business booming amid demand increase
|
|
willbah
|
13 |
3.8K |
1 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
13
|
3.8K
|
1
|
|
ASX - By Stock
|
ALI |
Re:
Ann: Weekly NTA estimate - Fri 27.3.20
|
|
willbah
|
1 |
728 |
2 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
1
|
728
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Micro-X (ASX:MX1) business booming amid demand increase
|
|
willbah
|
13 |
3.8K |
2 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
13
|
3.8K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
|
|
willbah
|
22 |
8.8K |
3 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
22
|
8.8K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
|
|
willbah
|
22 |
8.8K |
6 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
22
|
8.8K
|
6
|
|
ASX - By Stock
|
AFI |
Re:
Ann: Pre-Tax Estimated NTA - 13 March 2020
|
|
willbah
|
7 |
8.0K |
3 |
27/03/20 |
27/03/20 |
ASX - By Stock
|
7
|
8.0K
|
3
|
|
ASX - By Stock
|
ALX |
Re:
Ann: Market update regarding COVID-19 and distribution guidance
|
|
willbah
|
6 |
2.6K |
0 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
6
|
2.6K
|
0
|
|
ASX - By Stock
|
ALX |
Re:
Ann: Market update regarding COVID-19 and distribution guidance
|
|
willbah
|
6 |
2.6K |
2 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
6
|
2.6K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
How important is radiology in diagnosing COVID-19 infection?
|
|
willbah
|
32 |
9.0K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
32
|
9.0K
|
0
|
|
ASX - By Stock
|
AFI |
Re:
Ann: Pre-Tax Estimated NTA - 13 March 2020
|
|
willbah
|
7 |
8.0K |
0 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
7
|
8.0K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
How important is radiology in diagnosing COVID-19 infection?
|
|
willbah
|
32 |
9.0K |
1 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
32
|
9.0K
|
1
|
|
ASX - By Stock
|
AFI |
Re:
Ann: Pre-Tax Estimated NTA - 13 March 2020
|
|
willbah
|
7 |
8.0K |
1 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
7
|
8.0K
|
1
|
|
ASX - By Stock
|
CBA |
Re:
Commsec
|
|
willbah
|
25 |
11K |
2 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
25
|
11K
|
2
|
|
ASX - By Stock
|
ALI |
Re:
Ann: Entitlement Offer withdrawn
|
|
willbah
|
1 |
644 |
1 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
1
|
644
|
1
|
|
ASX - By Stock
|
ALX |
Re:
Ann: Completion of APRR Transaction
|
|
willbah
|
1 |
2.6K |
0 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
1
|
2.6K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
We hit my 4c target - should it now be 3c?
|
|
willbah
|
8 |
178K |
1 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
8
|
178K
|
1
|
|
ASX - By Stock
|
BNO |
Re:
Net Asset Backing is MINUS 0.3c
|
|
willbah
|
3 |
43K |
1 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
3
|
43K
|
1
|
|
ASX - By Stock
|
VTH |
Re:
Ann: 1H20 Statutory Accounts and Appendix 4D
|
|
willbah
|
8 |
62K |
0 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
8
|
62K
|
0
|
|
ASX - By Stock
|
VTH |
Re:
Ann: 1H20 Statutory Accounts and Appendix 4D
|
|
willbah
|
8 |
62K |
1 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
8
|
62K
|
1
|
|
ASX - By Stock
|
VTH |
Re:
Ann: 1H20 Statutory Accounts and Appendix 4D
|
|
willbah
|
8 |
62K |
0 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
8
|
62K
|
0
|
|
ASX - By Stock
|
ASX |
Re:
ASX is sued by ISX in Fed court
|
|
willbah
|
245 |
309K |
1 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
245
|
309K
|
1
|
|
ASX - By Stock
|
ASX |
Re:
ASX is sued by ISX in Fed court
|
|
willbah
|
245 |
309K |
0 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
245
|
309K
|
0
|
|
ASX - By Stock
|
ASX |
Re:
ASX is sued by ISX in Fed court
|
|
willbah
|
245 |
309K |
0 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
245
|
309K
|
0
|
|
ASX - By Stock
|
ASX |
Re:
ASX is sued by ISX in Fed court
|
|
willbah
|
245 |
309K |
0 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
245
|
309K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Cevaris testing shows positive results in bladder control
|
|
willbah
|
6 |
12K |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
6
|
12K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Cevaris testing shows positive results in bladder control
|
|
willbah
|
6 |
12K |
1 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
6
|
12K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira Meets Primary Endpoints for Insomnia Trial
|
|
willbah
|
268 |
199K |
0 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
268
|
199K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
willbah
|
12 |
9.1K |
4 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
12
|
9.1K
|
4
|
|
ASX - By Stock
|
SP1 |
Re:
ASIC revenue recognition & performance rights inquires....
|
|
willbah
|
289 |
203K |
0 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
289
|
203K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Appendix 4D & Half-Year Financial Report
|
|
willbah
|
2 |
1.8K |
1 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
2
|
1.8K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
willbah
|
12 |
9.1K |
1 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
12
|
9.1K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
willbah
|
12 |
9.1K |
2 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
12
|
9.1K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
willbah
|
12 |
9.1K |
3 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
12
|
9.1K
|
3
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
willbah
|
12 |
9.1K |
1 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
12
|
9.1K
|
1
|
|
ASX - By Stock
|
LVT |
Re:
Ann: Q2 ARR grows to $52.7 million
|
|
willbah
|
190 |
122K |
14 |
16/01/20 |
16/01/20 |
ASX - By Stock
|
190
|
122K
|
14
|
|
ASX - By Stock
|
ALX |
Re:
Ann: Ceasing to be a substantial holder
|
|
willbah
|
1 |
1.1K |
0 |
16/01/20 |
16/01/20 |
ASX - By Stock
|
1
|
1.1K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
willbah
|
44 |
30K |
1 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
44
|
30K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appendix 4C - quarterly
|
|
willbah
|
44 |
30K |
2 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
44
|
30K
|
2
|
|
ASX - By Stock
|
ARG |
Re:
Ann: App 3D - Renewal of on-market buyback
|
|
willbah
|
14 |
36K |
0 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
14
|
36K
|
0
|
|
ASX - By Stock
|
ARG |
Re:
Ann: App 3D - Renewal of on-market buyback
|
|
willbah
|
14 |
36K |
2 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
14
|
36K
|
2
|
|
ASX - By Stock
|
SP1 |
Re:
Epic Rap Battle ISX vs ASX
|
|
willbah
|
8 |
7.5K |
0 |
13/12/19 |
13/12/19 |
ASX - By Stock
|
8
|
7.5K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Some light relief in these troubling times
|
|
willbah
|
29 |
15K |
0 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
29
|
15K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Sale of French Subsidiaries to Domain Therapeutics
|
|
willbah
|
57 |
26K |
0 |
11/12/19 |
11/12/19 |
ASX - By Stock
|
57
|
26K
|
0
|
|
ASX - By Stock
|
SP1 |
Re:
Market Herald posts ISX
|
|
willbah
|
15 |
8.2K |
3 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
15
|
8.2K
|
3
|
|
ASX - By Stock
|
SP1 |
Re:
Ann: Commences Federal Court Action against ASX
|
|
willbah
|
2.7K |
1.2M |
30 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
2.7K
|
1.2M
|
30
|
|